Weekly gemcitabine (GEM) and 5-fluorouracil (5-FU) in pancreatic carcinoma. Phase I–II study

Authors :: M. Specchia
L. Angelelli
P. Tarantini
Carmelo Pozzo
Alessandra Cassano
C. Signorelli
Domenico Corsi
C. Barone
Source :: European Journal of Cancer. 35:S156
Publication Year :: 1999
Publisher :: Elsevier BV, 1999.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Phase i ii
business.industry
Fluorouracil
Internal medicine
Medicine
Pancreatic carcinoma
business
Gemcitabine
medicine.drug

Full Text Access

Tools